Share

April 14, 2020; 94 (15 Supplement) Tuesday, April 28

Natural History of Type 2 and 3 Spinal Muscular Atrophy (SMA): Longitudinal 2-year NatHis-SMA Study (530)

Laurent Servais, Andreea Mihaela Seferian, Aurore Daron, Yann Péréon, Claude Cances, Carole Vuillerot, Liesbeth MH De Waele, Vincent Laugel, Ulrike Schara, Teresa Gidaro, Charlotte Lilien, Jean-Yves Hogrel, Pierre-Yves Baudin, Pierre Carlier, Emmanuel Fournier, Linda Pax Lowes, Ksenija Gorni, Myriam Ly-Le Moal, Nicole Hellbach, Timothy Seabrook, Christian Czech, Ricardo Hermosilla, Mélanie Annoussamy
First published April 14, 2020,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 94 no. 15 Supplement 530
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 14, 2020.
Copyright & Usage: 
© 2020

Author Disclosures

    1. Laurent Servais1,2,3,
    2. Andreea Mihaela Seferian1,
    3. Aurore Daron2,
    4. Yann Péréon4,
    5. Claude Cances5,6,
    6. Carole Vuillerot7,
    7. Liesbeth MH De Waele8,9,
    8. Vincent Laugel10,
    9. Ulrike Schara11,
    10. Teresa Gidaro1,
    11. Charlotte Lilien1,
    12. Jean-Yves Hogrel1,
    13. Pierre-Yves Baudin12,
    14. Pierre Carlier1,
    15. Emmanuel Fournier1,
    16. Linda Pax Lowes13,
    17. Ksenija Gorni14,
    18. Myriam Ly-Le Moal15,
    19. Nicole Hellbach14,
    20. Timothy Seabrook14,
    21. Christian Czech16,
    22. Ricardo Hermosilla14 and
    23. Mélanie Annoussamy
    24. on behalf of the NatHis-SMA Study Group1
  1. Laurent Servais1,2,3,
  2. Andreea Mihaela Seferian1,
  3. Aurore Daron2,
  4. Yann Péréon4,
  5. Claude Cances5,6,
  6. Carole Vuillerot7,
  7. Liesbeth MH De Waele8,9,
  8. Vincent Laugel10,
  9. Ulrike Schara11,
  10. Teresa Gidaro1,
  11. Charlotte Lilien1,
  12. Jean-Yves Hogrel1,
  13. Pierre-Yves Baudin12,
  14. Pierre Carlier1,
  15. Emmanuel Fournier1,
  16. Linda Pax Lowes13,
  17. Ksenija Gorni14,
  18. Myriam Ly-Le Moal15,
  19. Nicole Hellbach14,
  20. Timothy Seabrook14,
  21. Christian Czech16,
  22. Ricardo Hermosilla14 and
  23. Mélanie Annoussamy
  1. 1Institute of Myology, GH Pitié Salpêtrière
  2. 2Centre de Référence des Maladies Neuromusculaires, CHU de Liège
  3. 3MDUK Oxford Neuromuscular Centre
  4. 4Centre de Référence Maladies Neuromusculaires Atlantique-Occitanie-Caraïbes, Hôpital Hôtel-Dieu
  5. 5Centre de Référence des Maladies Neuromusculaires, Hôpital des Enfants
  6. 6Unité de Neurologie Pédiatrique, Hôpital des Enfants
  7. 7Service de Rééducation Pédiatrique Infantile L’Escale, Hôpital Mère Enfant, CHU-Lyon
  8. 8Department of Pediatric Neurology, University Hospitals Leuven
  9. 9Department of Development and Regeneration, KU Leuven Kulak Kortijk
  10. 10Neuropédiatrie/INSERM CIC 1434, CHU Strasbourg Hautepierre
  11. 11Paediatric Neurology and Neuromuscular Center, University of Essen
  12. 12Consultants for Research in Imaging and Spectroscopy (CRIS)
  13. 13Center for Gene Therapy, Nationwide Children’s Hospital
  14. 14PDMA Neuroscience and Rare Disease, F. Hoffmann-La Roche Ltd.
  15. 15Institut Roche
  16. 16Therachon/Pfizer Rare Disease Unit, Pfizer

Article usage

Article usage: April 2020 to February 2023

AbstractFullPdfSource
Apr 2020500Highwire
May 20201600Highwire
Jun 2020500Highwire
Jul 2020500Highwire
Aug 2020900Highwire
Sep 2020900Highwire
Oct 20202800Highwire
Nov 20201400Highwire
Dec 20203200Highwire
Jan 20212400Highwire
Feb 20213500Highwire
Mar 20211200Highwire
Apr 20212300Highwire
May 20211400Highwire
Jun 2021800Highwire
Jul 20211300Highwire
Aug 20211400Highwire
Sep 20211200Highwire
Oct 2021800Highwire
Nov 20211000Highwire
Dec 20211000Highwire
Jan 20221300Highwire
Feb 2022700Highwire
Mar 20221700Highwire
Apr 20221100Highwire
May 20221100Highwire
Jun 20221200Highwire
Jul 2022700Highwire
Aug 2022300Highwire
Sep 20221000Highwire
Oct 2022500Highwire
Nov 20225800Highwire
Dec 20222400Highwire
Jan 20233000Highwire
Feb 20233400Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me